[ABT] Abbott Laboratories

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 38.41 Change: 0.12 (0.31%)
Ext. hours: Change: 0 (0%)

chart ABT

Refresh chart

Strongest Trends Summary For ABT

ABT is in the long-term up 112% in 4 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome, intrahepatic cholestasis or depressive symptoms, gynecological disorders, dyslipidemia, hypertension, hypothyroidism, pain, fever, and inflammation; and regulates physiological rhythm of the colon, as well as provides hormone replacement therapy and anti-infective and influenza vaccines. The company?s Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; hematology systems and reagents; genomic-based tests; informatics and automation solutions; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification,

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS0.94 EPS Growth - 4 Quarters1349.62% EPS Growth - Q/Q238.84%
EPS Growth - Y/Y-44.39% Sales Growth - 4 Quarters -18.92% Sales Growth - Q/Q-7.43% P/E51.29
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA9.75% ROE19.21% ROI12.44%
Current Ratio2.17 Quick Ratio1.89 Long Term Debt/Equity0.55 Debt Ratio0.42
Gross Margin55.74% Operating Margin13.95% Net Profit Margin20.6% Dividend Payout Ratio-32.44%
Dividend Yield
Fundamental Data
Cash From Financing Activities-550 M Cash From Investing Activities-205 M Cash From Operating Activities2 M Gross Profit2.95 B
Net Profit784 M Operating Profit729 M Total Assets43.1 B Total Current Assets19.99 B
Total Current Liabilities9.21 B Total Debt8.46 B Total Liabilities21.22 B Total Revenue5.17 B
Technical Data
High 52 week79.73 Low 52 week53.74 Last close75.97 Last change-0.82%
RSI36.28 Average true range1.51 Beta0.56 Volume3.81 M
Simple moving average 20 days-1.58% Simple moving average 50 days-2.29% Simple moving average 200 days14.05%
Performance Data
Performance Week-0.63% Performance Month4.24% Performance Quart1.37% Performance Half29.53%
Performance Year36.11% Performance Year-to-date22.22% Volatility daily1.12% Volatility weekly2.5%
Volatility monthly5.12% Volatility yearly17.75% Relative Volume228.71% Average Volume5.53 M
New High New Low

News

2019-09-17 09:00:00 | Abbott Announces European Approval of Two Life-saving Heart Devices for Babies and Children

2019-09-17 08:38:12 | Abbott Partners With Sanofi to Upgrade Diabetes Management

2019-09-16 17:50:09 | Abbott ABT Dips More Than Broader Markets: What You Should Know

2019-09-16 11:33:00 | Abbott Named the Industry Leader in Sustainability for the Seventh Consecutive Year on the Dow Jones Sustainability Index DJSI

2019-09-16 08:29:12 | Abbott's ABT FreeStyle Libre Gains Canadian Reimbursement

2019-09-16 08:00:00 | Abbott and Sanofi Partner to Integrate Glucose Sensing and Insulin Delivery Technologies to Help Change the Way Diabetes is Managed

2019-09-15 08:00:46 | Startup uses remittances to remove 'time and distance' from health care

2019-09-13 08:00:00 | Abbott's Revolutionary FreeStyle® Libre System Now Reimbursed in the Two Largest Provinces in Canada

2019-09-12 12:56:00 | Abbott Declares 383rd Consecutive Quarterly Dividend

2019-09-11 14:03:45 | Pharma Stock Calls Could Double Fast

2019-09-11 09:30:01 | Abbott Sees Hammer Chart Pattern: Time to Buy?

2019-09-10 17:45:09 | Abbott ABT Stock Sinks As Market Gains: What You Should Know

2019-09-10 09:00:00 | Abbott Announces New Data That Shows Artificial Intelligence Technology Can Help Doctors Better Determine Which Patients are Having a Heart Attack

2019-09-10 05:54:00 | Abbott Labs Falls 3%

2019-09-09 11:27:03 | Abbott ABT Launches Pivotal Trial TRILUMINATE in the US

2019-09-09 09:00:00 | Ministry of Health of Rwanda, Society for Family Health Rwanda and Abbott Launch Pioneering Model of Primary Health Care Service Delivery in Rwanda

2019-09-06 08:00:00 | He's Back and He's Hydrated: Abbott and NFL Star Odell Beckham Jr. Partner for Pedialyte®

2019-09-04 06:58:55 | Does Abbott Laboratories's NYSE:ABT CEO Salary Compare Well With Others?

2019-09-03 19:12:50 | Medtronic, Other Medtech Providers Could Face Additional Tariffs

2019-09-03 14:34:38 | How one company is working to improve equality in the STEM world

2019-09-03 08:11:12 | Here's Why You Should Hold on to Thermo Fisher TMO for Now

2019-09-03 07:02:11 | 5 Cancer-Fighting Stocks to Add to Your Portfolio

2019-08-31 07:29:00 | Is Dexcom a Buy?

2019-08-29 22:56:35 | Top 5 Recession Stocks

2019-08-28 17:50:09 | Abbott ABT Outpaces Stock Market Gains: What You Should Know

2019-08-27 08:56:12 | Here's Why You Should Add Abbott ABT to Your Portfolio

2019-08-27 08:54:12 | Abbott's ABT TRACK-TBI Study Reveals Encouraging Results

2019-08-26 09:30:01 | Has Abbott Laboratories ABT Outpaced Other Medical Stocks This Year?

2019-08-26 09:00:01 | Abbott ABT Upgraded to Buy: What Does It Mean for the Stock?

2019-08-26 09:00:00 | New Study Finds Abbott's Blood Test Technology Could Help Detect Brain Injury Quickly, Even if CT Scan is Normal

2019-08-26 07:00:00 | Together, We Can Increase the Number of Women in STEM: Here is a Tool to Help Companies Get Started

2019-08-25 07:30:00 | 3 Fantastic Stocks for Low-Risk Investors

2019-08-23 13:45:35 | Strategic Value Investing: Estimates of Cash Flows

2019-08-23 11:30:00 | Abbott Labs Falls 3%

2019-08-22 17:45:09 | Abbott ABT Dips More Than Broader Markets: What You Should Know

2019-08-22 11:45:03 | Abbott's Libre Adoption a Positive, Rhythm Management a Woe

2019-08-22 11:23:03 | The Zacks Analyst Blog Highlights: Home Depot, Abbott, Bristol-Myers, Activision and Marathon

2019-08-21 14:04:06 | Top Stock Reports for Home Depot, Abbott & Bristol-Myers

2019-08-21 11:05:03 | Tandem Diabetes Rides on t:slim X2 Uptake, Product Pipeline

2019-08-21 11:00:03 | FDA OKs Medtronic's Evolut TAVR New Indication for Low Risk

2019-08-21 10:05:00 | 3 Top Diabetes Stocks to Watch in August

2019-08-20 08:14:12 | Here's Why You Should Hold Onto IDEXX IDXX Stock for Now

2019-08-20 06:26:07 | Have Insiders Been Selling Abbott Laboratories NYSE:ABT Shares?

2019-08-16 09:30:01 | Abbott ABT Down 4.4% Since Last Earnings Report: Can It Rebound?

2019-08-14 10:42:00 | Abbott Labs Falls 3%

2019-08-14 09:00:00 | Abbott and Intoximeters Partner to Keep Roads Safer by Bringing Together Industry-leading Technology for Drug and Alcohol Testing

2019-08-14 08:38:12 | Zacks.com featured highlights include: Abbott Laboratories, Baxter International, First Horizon National, OUTFRONT Media and ICF International

2019-08-13 07:05:11 | 5 Stocks Trading Near 52-Week High With More Room to Run

2019-08-09 20:15:03 | Abbott Laboratories ABT Executive Vice President & CFO Brian B Yoor Sold $3. ...

2019-08-06 09:30:01 | Is Abbott Laboratories ABT Outperforming Other Medical Stocks This Year?